{
  "report_rows": [
    {
      "kpi": "Operating diluted EPS",
      "prediction": "IN-LINE",
      "answer": "pred ~$2.60 vs. cons $2.61",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Core organic revenue growth",
      "prediction": "MISS",
      "answer": "pred ~3.50% vs. cons 3.63%",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Operating EBITDA",
      "prediction": "IN-LINE",
      "answer": "pred ~$1.205B vs. cons $1.212B",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "Core organic growth (FY26)",
      "prediction": "BETTER",
      "answer": "guide ~4.0% vs. cons 3.73%",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Cost reductions (FY26)",
      "prediction": "UNCHANGED",
      "answer": "guide ~$900M vs. cons UNVERIFIED",
      "confidence": "LOW"
    }
  ],
  "day1_residual_pct": -1.5,
  "day1_confidence": "LOW",
  "day5_residual_pct": -3.0,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "FOLLOW-THROUGH \u2014 implied H2 organic-growth burden drives estimate risk",
  "day5_confidence": "LOW"
}